encompasses urological product/technologies, genital/reproductive medicine
The largest application for energy-based ablation devices is in cancer therapy, primarily using the radiation therapy modality. Following that is general surgery with its use of electrocautery and electrosurgical devices, RF ablation, cryotherapy, etc. Cardiovascular is thought to be third, even though cardiovascular is making the most noise in the medical press with RF and [...]
The applications of energy-based technologies for the ablative treatment of tissue are numerous and diverse as a result of the effectiveness of these technologies — which vary widely by energy type (electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet/hydrotherapy, microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation) — and their integration into routine [...]
PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue [...]
Cancer is a significant opportunity for the development of tissue engineering and cell therapies, but it is more than just an opportunity currently, since many companies are active and the market for cancer cell/tissue therapies already stands at nearly $500 million. Currently, OSI Pharmaceuticals has a commanding lead in this area, with its Tarceva [...]
The use of autologous, allogeneic and xenogeneic cells and tissues, the use of biomaterials, cell scaffolding and other approaches to tissue repair and regeneration has become part of arsenal of a number of clinical specialties, with high caseload and market revenue in these areas. In particular, orthopedics and skin applications are well established. And, while [...]
Our research into the products, technologies, companies and markets for tissue engineering and cell therapy has revealed that the 2009 market was at $6.9 billion. The market has grown dramatically, in commercialized products and company activity, over the past few years and is on an accelerated growth rate as technology hurdles are overcome and clinical [...]
(Report updated. See 2010 report on Ablation Technologies Worldwide.) The global market for medical devices is $200 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over [...]
In cardiovascular and spine surgery, multi-billion dollar markets were created from entirely new procedures between 1980 and 2000, with subsequent segmentation in later years particularly as new minimally invasive procedures were developed towards the end of the 20th century. In the cardiovascular arena, the development of new procedures for angioplasty and bypasses in the late [...]
Surgical management of soft tissues via "ablation" therapies, in which alternative energy types (radiation, electrosurgcal, ultrasound, etc.) are applied to excise, destroy, or otherwise produce a therapeutic effect at the tissue level has undergone a proliferation in development with all of these alternatives vying for caseload in clinical applications as diverse as tumor ablation, arrhythmia [...]
Following up on my post yesterday regarding ablation treatments for prostate cancer, one of the ablation modalities noted was HIFU, or high-intensity focused ultrasound. Unlike lasers, RF, microwave or cryotherapy, ultrasound offers superior control of energy output. 3D control and directionality of the energy delivered provides the ability to treat a prescribed target volume and shape [...]
Contact:
